Case report of preoperative radiotherapy followed by surgery in patient with giant primary retroperitoneal G1 liposarcoma-Reference-Cited by-同舟云学术

Case report of preoperative radiotherapy followed by surgery in patient with giant primary retroperitoneal G1 liposarcoma

Published:2022-12-01 Issue:3 Volume:12 Page:43-48
ISSN:2587-6813
Container-title:Malignant tumours
language:
Short-container-title:Malignant Tumours

Author:

Bart Yu. I.¹,Glibichuk D. A.²,Abdulaeva R. Sh.³,Avdyukhin I. G.¹,Kalinin А. Е.¹,Chernykh M. V.⁴

Affiliation:

1. N. N. Blokhin National Research Center of Oncology

2. Peoples’ Friendship University of Russia

3. Pirogov Russian National Research Medical University

4. N. N. Blokhin National Research Center of Oncology; Sechenov First Moscow State Medical University

Abstract

Despite the development of contemporary surgical management of retroperitoneal liposarcomas, local recurrence remains the major challenge in the treatment of these tumors. Currently, surgery is the main treatment option for liposarcoma. The international cancer community faces a global goal — the development of new combined treatment options for the treatment of retroperitoneal liposarcoma to reduce the postoperative recurrence rate and increase the overall survival. This article presents the world literature data on the treatment of retroperitoneal liposarcomas and demonstrates a case report describing treatment of a patient with this disease in the N. N. Blokhin NMRC of Oncology.

Publisher

Russian Society of Clinical Oncology

Subject

General Agricultural and Biological Sciences

Reference12 articles.

1. Ishii, K., Yokoyama, Y., Nishida, Y., Koike, H., Yamada, S., Kodera, Y., Sassa, N., Gotoh, M., & Nagino, M. (2020). Characteristics of primary and repeated recurrent retroperitoneal liposarcoma : Outcomes after aggressive surgeries at a single institution. Japanese Journal of Clinical Oncology, 50 (12), 1412–1418.

2. Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal Soft-Tissue Sarcoma Analysis of 500 Patients Treated and Followed at a Single Institution. Ann Surg. 1998.

3. Miao, C.-L., Zhang, L.-L., Tseng, W. W., Qiu, F.-B., Lu, W.-Q., Dai, Y.-G., Rao, X.-S., Li, W.-J., Zhang, G.-K., Chen, J., Liu, W.-Q., Chen, X.-B., Xiao, M.-M., Cha, L.-C., Wang, J.-Y., Ren, Y.-B., Yang, H.-Y., & Luo, C.-H. (2022). A better overall survival (OS) for total (ipsilateral) retroperitoneal lipectomy than standard complete resection in patients with retroperitoneal liposarcoma : a comparative multi-institutional study. Annals of Translational Medicine, 10 (14), 785–785.

4. Gronchi A, Miceli R, Allard MA, Callegaro D, le Péchoux C, Fiore M, et al. Personalizing the Approach to Retroperitoneal Soft Tissue Sarcoma : Histology-specific Patterns of Failure and Postrelapse Outcome after Primary Extended Resection. Ann Surg Oncol. Springer New York LLC ; 2015 ; 22 : 1447–54.

5. Gronchi A, Ferrari S, Quagliuolo V, Broto JM, Pousa AL, Grignani G, et al. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001) : an international, open-label, randomised, controlled, phase 3, multicentre trial. Lancet Oncol. Lancet Publishing Group ; 2017 ; 18 : 812–22.